The hosts of NPR's All Things Considered help you make sense of a major news story and what it means for you, in 15 minutes. New episodes six days a week, Sunday through Friday.Support NPR and get your news sponsor-free with Consider This+. Learn more at plus.npr.org/considerthis

The hosts of NPR's All Things Considered help you make sense of a major news story and what it means for you, in 15 minutes. New episodes six days a week, Sunday through Friday.<br><br><em>Support NPR and get your news sponsor-free with Consider This+. Learn more at plus.npr.org/considerthis</em>

Consider This from NPR

The FDA Advisory Committee decided not to approve boosters for people sixteen and up. Instead, they made a recommendation for those 65 and up, or younger people at high risk to get a booster shot right now from Pfizer-Biontech.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy

Berita Harian

Boosters Won't Make It To Everyone For Now, But Vaccines For Young Children Are Coming